Literature DB >> 17131472

Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor.

Jian Qi1, You-Qing Zhu, Jun Luo, Wen-Hui Tao.   

Abstract

AIM: To investigate the functions of promoter hyper-methylation of secreted frizzled-related proteins (sFRPs) genes in colorectal tumorigenesis and progression.
METHODS: The promoter hypermethylation and expression of sFRP genes in 72 sporadic colorectal carcinomas, 33 adenomas, 18 aberrant crypt foci (ACF) and colorectal cancer cell lines RKO, HCT116 and SW480 were detected by methylation-specific PCR and reverse transcription PCR, respectively.
RESULTS: None of the normal colorectal mucosa tissues showed methylated bands of any of four sFRP genes. sFRP1, 2, 4 and 5 were frequently methylated in colorectal carcinoma, adenoma and ACF (sFRP1 > 85%, sFRP2 > 75%, sFRP5 > 50%), and the differences between three colorectal tissues were not significant (P > 0.05). Methylation in colorectal tumors was more frequent than in normal mucosa and adjacent normal mucosa. The mRNA of sFRP1-5 genes was expressed in all normal colorectal mucosa samples. Expression of sFRP1, 2, 4 and 5 and sFRP1, 2 and 5 was downregulated in carcinoma and adenoma, respectively. The downregulation of sFRP2, 4 and 5 was more frequent in carcinoma than in adenoma. Expression of sFRP3 which promoter has no CpG island was downregulated in only a few of colorectal tumor samples (7/105). The downregulation of sFRP1, 2, 4 and 5 expression was significantly associated with promoter hypermethylation in colorectal tumor. After cells were treated by DAC/TSA combination, the silenced sFRP mRNA expression could be effectively re-expressed in colorectal cancer cell lines.
CONCLUSION: Hypermethylation of sFRP genes is a common early event in the evolution of colorectal tumor, occurring frequently in ACF, which is regarded as the earliest lesion of multistage colorectal carcinogenesis. It appears to functionally silence sFRP genes expression. Methylation of sFRP1, 2 and 5 genes might serve as indicators for colorectal tumor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131472      PMCID: PMC4087771          DOI: 10.3748/wjg.v12.i44.7113

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

Review 1.  Secreted Frizzled-related proteins: searching for relationships and patterns.

Authors:  Steve E Jones; Catherine Jomary
Journal:  Bioessays       Date:  2002-09       Impact factor: 4.345

Review 2.  Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance.

Authors:  H Doucas; G Garcea; C P Neal; M M Manson; D P Berry
Journal:  Eur J Cancer       Date:  2005-02       Impact factor: 9.162

Review 3.  The role of mammalian DNA methyltransferases in the regulation of gene expression.

Authors:  Justyna Turek-Plewa; Paweł P Jagodziński
Journal:  Cell Mol Biol Lett       Date:  2005       Impact factor: 5.787

Review 4.  APC, signal transduction and genetic instability in colorectal cancer.

Authors:  R Fodde; R Smits; H Clevers
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

5.  A gene hypermethylation profile of human cancer.

Authors:  M Esteller; P G Corn; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

6.  Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with K-ras G to A mutation in colorectal tumor.

Authors:  Jian Qi; You-Qing Zhu; Mei-Fang Huang; Dong Yang
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 7.  Secreted antagonists of the Wnt signalling pathway.

Authors:  Yoshiaki Kawano; Robert Kypta
Journal:  J Cell Sci       Date:  2003-07-01       Impact factor: 5.285

8.  Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.

Authors:  Amie Y Lee; Biao He; Liang You; Sina Dadfarmay; Zhidong Xu; Julien Mazieres; Iwao Mikami; Frank McCormick; David M Jablons
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

9.  Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.

Authors:  H Bouzourene; P Chaubert; W Seelentag; F T Bosman; E Saraga
Journal:  Hum Pathol       Date:  1999-01       Impact factor: 3.466

10.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.

Authors:  Hiromu Suzuki; D Neil Watkins; Kam-Wing Jair; Kornel E Schuebel; Sanford D Markowitz; Wei Dong Chen; Theresa P Pretlow; Bin Yang; Yoshimitsu Akiyama; Manon Van Engeland; Minoru Toyota; Takashi Tokino; Yuji Hinoda; Kohzoh Imai; James G Herman; Stephen B Baylin
Journal:  Nat Genet       Date:  2004-03-14       Impact factor: 38.330

View more
  57 in total

Review 1.  New trends in molecular and cellular biomarker discovery for colorectal cancer.

Authors:  Parisa Aghagolzadeh; Ramin Radpour
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Epigenetics and colorectal cancer.

Authors:  Victoria Valinluck Lao; William M Grady
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-18       Impact factor: 46.802

Review 3.  Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy.

Authors:  Li Song; Zhuo-Yu Li; Wei-Ping Liu; Mei-Rong Zhao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 4.  Accumulation of aberrant DNA methylation during colorectal cancer development.

Authors:  Eiji Sakai; Atsushi Nakajima; Atsushi Kaneda
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 5.  A Wnt survival guide: from flies to human disease.

Authors:  Andy J Chien; William H Conrad; Randall T Moon
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

6.  Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.

Authors:  Dao-Rong Wang; Dong Tang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 7.  Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.

Authors:  Laura Novellasdemunt; Pedro Antas; Vivian S W Li
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-19       Impact factor: 4.249

8.  Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.

Authors:  Myoung Sook Kim; Joost Louwagie; Beatriz Carvalho; Jochim S Terhaar Sive Droste; Hannah Lui Park; Young Kwang Chae; Keishi Yamashita; Junwei Liu; Kimberly Laskie Ostrow; Shizhang Ling; Rafael Guerrero-Preston; Semra Demokan; Zubeyde Yalniz; Nejat Dalay; Gerrit A Meijer; Wim Van Criekinge; David Sidransky
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

9.  Aberrant methylation inactivates transforming growth factor Beta receptor I in head and neck squamous cell carcinoma.

Authors:  Teresita Muñoz-Antonia; Mariclara Torrellas-Ruiz; Jonathan Clavell; Linda A Mathews; Carlos A Muro-Cacho; Adriana Báez
Journal:  Int J Otolaryngol       Date:  2009-06-14

10.  Integrative genome comparison of primary and metastatic melanomas.

Authors:  Omar Kabbarah; Cristina Nogueira; Bin Feng; Rosalynn M Nazarian; Marcus Bosenberg; Min Wu; Kenneth L Scott; Lawrence N Kwong; Yonghong Xiao; Carlos Cordon-Cardo; Scott R Granter; Sridhar Ramaswamy; Todd Golub; Lyn M Duncan; Stephan N Wagner; Cameron Brennan; Lynda Chin
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.